Vanda Pharmaceuticals Inc. (VNDA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2012-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

Older than the company's other figures. The latest EBITDA is for the year ended 2014-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

$20.59M
Year ended 2014-12-31
2009-12-31: -$35.51M2010-12-31: $9.17M2011-12-31: -$10.24M2012-12-31: -$28.55M2013-12-31: -$20.77M2014-12-31: $20.59M$20.59M
2009-12-31 EBITDA (USD) 2014-12-31
Period endedEBITDAChange YoYSource filing
2014-12-31$20.59Mn/m2017-02-17, From 2014-01-01
2013-12-31-$20.77Mn/m2016-02-12, From 2013-01-01
2012-12-31-$28.55Mn/c2015-03-13, From 2012-01-01
2011-12-31-$10.24Mn/m2014-02-25, From 2011-01-01
2010-12-31$9.17Mn/m2013-02-26, From 2010-01-01
2009-12-31-$35.51Mn/a2012-03-09, From 2009-01-01